Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$26.74 - $40.81 $39,307 - $59,990
1,470 Added 58.87%
3,967 $106,000
Q2 2023

Aug 14, 2023

BUY
$28.52 - $40.7 $51,022 - $72,812
1,789 Added 252.68%
2,497 $92,000
Q1 2023

May 15, 2023

SELL
$29.39 - $36.27 $56,810 - $70,109
-1,933 Reduced 73.19%
708 $22,000
Q4 2022

Feb 14, 2023

BUY
$29.23 - $40.28 $77,196 - $106,379
2,641 New
2,641 $0

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.